CJC-1295 (with DAC)
CJC-1295 (with DAC) risk profile, scheduling, and guidance for claims professionals and care workers .
CJC-1295 (with DAC) is classified as Moderate risk (3 risk points) by AllMeds. Growth hormone releasing peptide. NOT TGA registered. Compounding only. Safety concerns.
Key Takeaways
- Risk level: Moderate (3 points)
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | Unscheduled | Not PBS listed |
Risk Profile
Growth hormone releasing peptide. NOT TGA registered. Compounding only. Safety concerns.
Regulatory and Compliance Guidance
When CJC-1295 (with DAC) appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as Unscheduled under the Therapeutic Goods Administration (TGA).
Clinical Evidence
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295 (2006)
Phase I/II clinical trial showing CJC-1295 increases GH and IGF-1 levels. Study by ConjuChem (manufacturer). Development discontinued.
Published human trial but drug development was abandoned — manufacturer-funded
- Deaths linked to peptide use in bodybuilding community (2023)
Multiple Australian media reports of adverse events associated with GH-releasing peptides obtained from unregulated sources.
Major national broadcaster — credible journalism
- TGA: Growth hormone secretagogue peptides — safety concerns (2023)
TGA warns that GH-releasing peptides from compounding pharmacies are not registered medicines. Quality, safety, and efficacy not established.
Australian regulatory authority
Need to assess this medication across your caseload?
Run a full risk assessment including CJC-1295 (with DAC) interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.